2025

Dr. Roser Velasco, co-lead author of an international guideline on the management of neurological complications in CAR-T cell treatments

Dr. Roser Velasco, IDIBELL principal investigator at Neuro-Oncology group and neurologist at the Neuro-Oncology Unit of ICO Hospitalet and Bellvitge University Hospital, has co-directed the writing of an international guide of recommendations on the management of neurological complications associated with CAR-T cell therapy. Dr. Velasco has participated as an expert in neuro-oncology within the Committee […]

Dr. Roser Velasco, co-lead author of an international guideline on the management of neurological complications in CAR-T cell treatments Read More »

Gene therapy reverses the symptoms of a rare neurological disease in animal models

Megaloencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare childhood disease that mainly affects the white matter of the brain. Among other symptoms, it is characterized by macrocephaly, inability to coordinate motor movements, and epilepsy. More than 75% of diagnosed cases are due to mutations in the MLC1 gene, which encodes a protein located in

Gene therapy reverses the symptoms of a rare neurological disease in animal models Read More »

A multicentre study warns of the increase in severe Streptococcus dysgalactiae infections in Spain

The significant increase in serious infections caused by S.dysgalactiae is confirmed, reaffirming the need to strengthen detection and surveillance systems

A multicentre study warns of the increase in severe Streptococcus dysgalactiae infections in Spain Read More »

IDIBELL brings neuroscience closer to the public within the framework of the Brain Week in L’Hospitalet

IDIBELL presented two talks on neuroscience research within the Pessics de Ciència cycle

IDIBELL brings neuroscience closer to the public within the framework of the Brain Week in L’Hospitalet Read More »

Scroll to Top